Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link

Volume 32, Number 3—March 2026

Dispatch

Home-Based Monitoring of Treatment-Related Adverse Events during Drug-Resistant Tuberculosis Treatment, India, 2020–2024

Minal Ahson, Daksha Shah, Sampada Bhide, Rajesh Deshmukh, Jonathan P. Smith, Smita Waghmare, Satish Kaipilyawar, Varsha Puri, Dilip K. Khetade, Vijay Yeldandi, Anand Date, Patrick K. Moonan1, and Christine S. Ho1Comments to Author 
Author affiliation: Centers for Disease Control and Prevention, Atlanta, Georgia, USA (M. Ahson, J.P. Smith, A. Date, P.K. Moonan, C.S. Ho); Brihanmumbai Municipal Corporation, Mumbai, India (D. Shah, V. Puri, D.K. Khetade); Society for Health Allied Research and Education, Hyderabad, India (S. Bhide, S. Waghmare, S. Kaipilyawar, V. Yeldandi); US Centers for Disease Control and Prevention, Mumbai (R. Deshmukh)

Main Article

Figure

Cumulative incidence function curves of time to first clinical adverse events in a study of home-based monitoring of treatment-related adverse events during drug-resistant tuberculosis treatment, Dharavi, Mumbai, India, 2020‒2024. Graphs compare reactions between patients with injectable versus noninjectable treatment regimens among patients with drug-resistant TB. Solid lines indicate medians; dotted lines indicate 95% CIs. sHR, subdistribution hazard ratio.

Figure. Cumulative incidence function curves of time to first clinical adverse events in a study of home-based monitoring of treatment-related adverse events during drug-resistant tuberculosis treatment, Dharavi, Mumbai, India, 2020‒2024. Graphs compare reactions between patients with injectable versus noninjectable treatment regimens among patients with drug-resistant TB. Solid lines indicate medians; dotted lines indicate 95% CIs. sHR, subdistribution hazard ratio.

Main Article

1These authors contributed equally to this article.

Page created: February 20, 2026
Page updated: March 20, 2026
Page reviewed: March 20, 2026
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external